Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1110850 | 0.72 | GPR84 (0.53) | POLBLMNAGPR84MAPTTDP1 | |
| SCHEMBL3538062 | 0.72 | HTT (0.54) | POLBLMNAGPR84MAPTTDP1 | |
| SCHEMBL5094216 | 0.71 | GPR84 (0.88) | POLBLMNAGPR84SMN1; SMN2 | |
| SCHEMBL11338091 | 0.71 | MAPT (0.57) | POLBLMNAGPR84MAPTTDP1 | |
| SCHEMBL16910484 | 0.71 | POLB (0.50) | POLBLMNAGPR84MAPTTDP1 | |
| SCHEMBL8752020 | 0.70 | POLB (0.63) | POLBLMNAGPR84MAPTTDP1 | |
| SCHEMBL3951972 | 0.70 | GPR84 (0.57) | POLBLMNAGPR84MAPTTDP1 | |
| SCHEMBL15574997 | 0.70 | POLB (0.68) | POLBLMNAGPR84MAPTTDP1 | |
| SCHEMBL3464397 | 0.70 | — | — | |
| SCHEMBL10475123 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765774-B2 | 3-arylquinazolin-4-one compounds for combating invertebrate pests | BASF SE (DE) | 2014-07-01 | — | — | US | disclosed |
| EP-2403837-B1 | 3-ARYLQUINAZOLIN-4-ONE COMPOUNDS FOR COMBATING INVERTEBRATE PESTS | BASF SE (DE) | 2013-12-11 | — | — | EP | disclosed |
| US-20120053052-A1 | 3-Arylquinazolin-4-one compounds for combating invertebrate pests | BASF SE (DE) | 2012-03-01 | — | — | US | disclosed |
| EP-2403837-A1 | 3-ARYLQUINAZOLIN-4-ONE COMPOUNDS FOR COMBATING INVERTEBRATE PESTS | BASF SE (DE) | 2012-01-11 | — | — | EP | disclosed |
| WO-2010100189-A1 | 3-ARYLQUINAZOLIN-4-ONE COMPOUNDS FOR COMBATING INVERTEBRATE PESTS | BASF SE (DE) | 2010-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053052-A1 | 3-Arylquinazolin-4-one compounds for combating invertebrate pests | CBR3, CNPY3, RTN3 | POLB 4729/4885LMNA 3408/4885GPR84 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.